Evidence map›Paper›PMID 23929039›Full record

ArticleInternational journal of cancer2014

Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma.

Jocelyn H Wright, Melissa M Johnson, Masami Shimizu-Albergine, Renay L Bauer, Brian J Hayes, James Surapisitchat, Kelly L Hudkins, Kimberly J Riehle, Simon C Johnson, Matthew M Yeh and 6 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in International journal of cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Roles of PDGF/PDGFR signaling in various organs.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2025
    Review
  5. Article
  6. Article
  7. Friend or foe? The elusive role of hepatic stellate cells in liver cancer.Nature reviews. Gastroenterology & hepatology · 2023
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Hepatic Stellate Cells and Hepatocarcinogenesis.Frontiers in cell and developmental biology · 2020
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 2 countries.

Jocelyn H WrightDepartment of Pathology, University of Washington, Seattle, WA.
Melissa M Johnson
Masami Shimizu-Albergine
Renay L Bauer
Brian J Hayes
James Surapisitchat
Kelly L Hudkins
Kimberly J Riehle
Simon C Johnson
Matthew M Yeh
Theodor K Bammler
Richard P Beyer
Debra G Gilbertson
Charles E Alpers
Nelson Fausto
Jean S Campbell
University of Washington · USBristol-Myers Squibb (Germany) · DE

Funding

XENOBIOTIC BIOTRANSFORMATION AND DISPOSITIONP30ES007033 · NIEHS · UNIVERSITY OF WASHINGTON · PI ALI SHOJAIE · 1995 to 2026
$42.5M
EXPERIMENTAL PATHOLOGY OF CARDIOVASCULAR DISEASET32HL007312 · NHLBI · UNIVERSITY OF WASHINGTON · PI MAJESKY, MARK W., SCHWARTZ, STEPHEN MARK · 1985 to 2019
$11.8M
CARDIOVASCULAR RESEARCH TRAINING PROGRAMT32HL007828 · NHLBI · UNIVERSITY OF WASHINGTON · PI Francis Kim, Farid Moussavi-Harami · 1997 to 2026
$10.2M
GENE EXPRESSION IN REGENERATING AND NEOPLASTIC LIVERSR37CA023226 · NCI · UNIVERSITY OF WASHINGTON · PI FAUSTO, NELSON · 2001 to 2009
$3.1M
Pathogenesis of Hepatocellular CarcinomasR01CA074131 · NCI · UNIVERSITY OF WASHINGTON · PI FAUSTO, NELSON · 1997 to 2010
$3.1M
Mechanisms of PDGF-C Induced Hepatocellular CarcinogenesisR01CA127228 · NCI · UNIVERSITY OF WASHINGTON · PI CAMPBELL, JEAN S · 2007 to 2011
$1.5M
GENE EXPRESSION IN REGENERATING AND NEOPLASTIC LIVERSR01CA023226 · NCI · UNIVERSITY OF WASHINGTON · PI FAUSTO, NELSON · 1985 to 2000
$359k
Howard Hughes Medical InstituteNCI NIH HHS CA023226NCI NIH HHS CA074131NCI NIH HHS CA127228NCI NIH HHS R01 CA023226NCI NIH HHS R01 CA074131NCI NIH HHS R01 CA127228NCI NIH HHS R37 CA023226NHLBI NIH HHS HL007312NHLBI NIH HHS T32 HL007312NHLBI NIH HHS T32 HL007828NIEHS NIH HHS P30 ES007033NIEHS NIH HHS P30ES07033
6 · The paper itself

Abstract

Cirrhosis is the primary risk factor for the development of hepatocellular carcinoma (HCC), yet the mechanisms by which cirrhosis predisposes to carcinogenesis are poorly understood. Using a mouse model that recapitulates many aspects of the pathophysiology of human liver disease, we explored the mechanisms by which changes in the liver microenvironment induce dysplasia and HCC. Hepatic expression of platelet-derived growth factor C (PDGF-C) induces progressive fibrosis, chronic inflammation, neoangiogenesis and sinusoidal congestion, as well as global changes in gene expression. Using reporter mice, immunofluorescence, immunohistochemistry and liver cell isolation, we demonstrate that receptors for PDGF-CC are localized on hepatic stellate cells (HSCs), which proliferate, and transform into myofibroblast-like cells that deposit extracellular matrix and lead to production of growth factors and cytokines. We demonstrate induction of cytokine genes at 2 months, and stromal cell-derived hepatocyte growth factors that coincide with the onset of dysplasia at 4 months. Our results support a paracrine signaling model wherein hepatocyte-derived PDGF-C stimulates widespread HSC activation throughout the liver leading to chronic inflammation, liver injury and architectural changes. These complex changes to the liver microenvironment precede the development of HCC. Further, increased PDGF-CC levels were observed in livers of patients with nonalcoholic fatty steatohepatitis and correlate with the stage of disease, suggesting a role for this growth factor in chronic liver disease in humans. PDGF-C transgenic mice provide a unique model for the in vivo study of tumor-stromal interactions in the liver.

Indexed as

Paracrine CommunicationAnimalsBiomarkers, TumorBlotting, WesternCarcinoma, HepatocellularCohort StudiesCytokinesFatty LiverFluorescent Antibody TechniqueGene Expression ProfilingHepatic Stellate CellsHepatocytesHumansImmunoenzyme TechniquesInflammationLiverBiomarkers, TumorCytokinesLymphokinesPlatelet-Derived Growth Factorplatelet-derived growth factor CRNA, Messengerhepatocellular carcinomamicroenvironmentPDGFstromal cell

Identifiers

PMID23929039
PMCPMC3876966
OpenAlexW1593389454

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.